Abstract:Shasha Liu, 1 Jinxue Wei, 2, 3 Rongjun Ni, 2, 3 Tianhao Gao, 1 Peiyan Ni, 2, 3 Liansheng Zhao, 2, 3 Xiyu Duan, 2, 3 Xiaohong Ma, 2, 3 Pak C Sham, 4, 5 Tao Li 1– 3, 6 1 Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, People's Republic of China; 2 Psychiatric Laboratory and Mental Health Center, West China Hospital of Sichuan University, Chengdu, People's Republic of China; 3 Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, People's Republic of China; 4 Department of Psychiatry, The University of Hong Kong, Pokfulam, Hong Kong, People's Republic of China; 5 State Key Laboratory for Cognitive and Brain Sciences, The University of Hong Kong, Pokfulam, Hong Kong, People's Republic of China; 6 Guangdong-Hong Kong-Macao Greater Bay Area Center for Brain Science and Brain-Inspired Intelligence, Guangzhou, People's Republic of China Correspondence: Tao Li Psychiatric Laboratory of West China Hospital, Sichuan University, 1 Keyuan Si Road, Chengdu, Sichuan, 610041, People's Republic of China Email litaohx@scu.edu.cn Background: Mice with a deletion at exon 19 of the circadian locomotor output cycles Kaput gene ( Clock delta19 ) exhibit mania-like behavior and have been one of the most common animal models for bipolar disorder (BD). The predictive validity of the Clock delta19 was investigated via studies using lithium previously. Determination of effects of other mood stabilizers on Clock delta19 mouse would be helpful for better understanding of the mechanism underlined. Methods: Wildtype (WT) and Clock delta19 mice were treated with saline (n = 10 for WT and n=10 for Clock delta19 ) or valproate (VPA) (n = 10 for WT and n=10 for Clock delta19 ) for 10 days. The hyperactivity, anxiety-like behaviors and depression-like behaviors were tested. The concentration of monoamine neurotransmitters and their metabolites in the hippocampus of saline or VPA treated WT and Clock delta19 mouse (n = 8 for each) were also determined. Results: VPA can reverse hyperactivity, lower level of anxiety-like and depression-like behaviors of the Clock delta19 mouse. Clock delta19 mouse exhibited lower levels of serotonin (5-HT) and dopamine (DA) in right hippocampus compared to WT mouse. Chronic VPA treatment did not affect the levels of 5-HT and DA, but can reduce the level of levodopa (L-DOPA) in the right hippocampus of Clock delta19 mouse. Conclusion: Our results indicated that chronic VPA treatment can reverse the mania-like behaviors of the Clock delta19 mouse and further consolidate the validity of the Clock delta19 mouse as a model of BD. Monoamine neurotransmitters and their metabolites in the hippocampus are partly regulated by mutation of the Clock gene or VPA treatment. Keywords: bipolar disorder, Clock delta19 mouse, valproate, mania-like behavior, neurotransmitter

Effects of lithium and valproate on ERK/JNK signaling pathway in an animal model of mania induced by amphetamine

Anti‐manic effect of deep brain stimulation of the ventral tegmental area in an animal model of mania induced by methamphetamine

Effects of Mood Stabilizers on Brain Energy Metabolism in Mice Submitted to an Animal Model of Mania Induced by Paradoxical Sleep Deprivation

Omega-3 Fatty Acids and Mood Stabilizers Alter Behavioural and Energy Metabolism Parameters in Animals Subjected to an Animal Model of Mania Induced by Fenproporex

Akt and AMPK activators rescue hyperexcitability in neurons from patients with bipolar disorder

Valproate Reverses Mania-Like Behavior of Clock Delta19 Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus.

Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations

Chronic lithium treatment ameliorates ketamine-induced mania-like behavior via the PI3K-AKT signaling pathway

Imipramine Can Be Effective on Depressive-Like Behaviors, but Not on Neurotrophic Factor Levels in an Animal Model for Bipolar Disorder Induced by Ouabain

Modulation of Synaptic Plasticity by Antimanic Agents: the Role of AMPA Glutamate Receptor Subunit 1 Synaptic Expression.

Doxycycline reversal of amphetamine-induced mania-like behavior is related to adjusting brain monoamine abnormalities and antioxidant effects in primary hippocampal neurons

Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene

Valproate Reverses Mania-Like Behavior of Clockdelta19 Mouse and Alters Monoamine Neurotransmitters Metabolism in the Hippocampus

Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers

Gene expression effects of lithium and valproic acid in a serotonergic cell line

Valproic acid activates ERK-1/2 signaling pathway in the rat hippocampus and frontal cortex

Valproate Inhibits Methamphetamine Induced Hyperactivity Via Glycogen Synthase Kinase 3 Beta Signaling In The Nucleus Accumbens Core

Effect of blueberry extract on energetic metabolism, levels of brain-derived neurotrophic factor, and Ca2+-ATPase activity in the hippocampus and cerebral cortex of rats submitted to ketamine-induced mania-like behavior

Chronic lithium exposure attenuates ketamine-induced mania-like behavior and c-Fos expression in the forebrain of mice

Contribution of neuronal calcium sensor 1 (Ncs-1) to anxiolytic-like and social behavior mediated by valproate and Gsk3 inhibition

The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms